Kiniksa Pharmaceuticals, Ltd.
NasdaqGS:KNSA
$ 17.88
$0.00 (0.00%)
$ 17.88
$0.00 (0.00%)
End-of-day quote: 04/27/2024

KNSA - Kiniksa Pharmaceuticals Stock Prediction 2025 - 2030

6 years of reliable Kiniksa Pharmaceuticals stock forecast. The Wall Street analysts predict Buy for KNSA. See at a glance whether NasdaqGS:KNSA will rise in the future.

$3.00
Forecast 2023
$20.79
Forecast 2025
$32.51
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$3.00
Forecast 2025
$20.79
Forecast 2030
$32.51
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.3
Price-to-book Ratio
2.93
Market Cap
1.25B
TEV
1.05 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$27.20
Country

Kiniksa Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Kiniksa Pharmaceuticals Stock Forecast 2023

$30.00

In the last five quarters, Kiniksa Pharmaceuticals’s Price Target has risen from $20.49 to $27.20 - a 32.75% increase. Three analysts predict that Kiniksa Pharmaceuticals’s share price will increase in the coming year, reaching $30.00. This would represent an increase of 10.29%.

67.79%
67.79
Last update: 04/27/2024

Highest Price Target $32.00

Average Price Target $30.00

Lowest Price Target $26.00

Kiniksa Pharmaceuticals Stock Forecast 2025

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Jan 2025.

In Jan 2025 analysts predict a share price of $19.16. An increase of 7.13% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Feb 2025.

In Feb 2025 analysts predict a share price of $19.30. An increase of 7.96% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Mar 2025.

In Mar 2025 analysts predict a share price of $19.45. An increase of 8.79% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Apr 2025.

In Apr 2025 analysts predict a share price of $19.60. An increase of 9.62% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in May 2025.

In May 2025 analysts predict a share price of $19.75. An increase of 10.45% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Jun 2025.

In Jun 2025 analysts predict a share price of $19.90. An increase of 11.28% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Jul 2025.

In Jul 2025 analysts predict a share price of $20.04. An increase of 12.11% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Aug 2025.

In Aug 2025 analysts predict a share price of $20.19. An increase of 12.94% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Sep 2025.

In Sep 2025 analysts predict a share price of $20.34. An increase of 13.77% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Oct 2025.

In Oct 2025 analysts predict a share price of $20.49. An increase of 14.6% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Nov 2025.

In Nov 2025 analysts predict a share price of $20.64. An increase of 15.43% compared to today's share price.

Stock Prediction for the Price of One Kiniksa Pharmaceuticals Share in Dec 2025.

In Dec 2025 analysts predict a share price of $20.79. An increase of 16.25% compared to today's share price.

Kiniksa Pharmaceuticals Stock Predictions 2030

Kiniksa Pharmaceuticals Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $29.96. An increase of 67.58% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $30.19. An increase of 68.88% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $30.43. An increase of 70.17% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $30.66. An increase of 71.47% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $30.89. An increase of 72.77% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $31.12. An increase of 74.06% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $31.35. An increase of 75.36% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $31.59. An increase of 76.66% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $31.82. An increase of 77.95% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $32.05. An increase of 79.25% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $32.28. An increase of 80.55% compared to the previous month's estimate.

Kiniksa Pharmaceuticals Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $32.51. An increase of 81.84% compared to the previous month's estimate.

P/E
0.00
Beta
0.3
Price-to-book Ratio
2.93
Market Cap
1.25B
TEV
1.05 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$27.20
Country

Kiniksa Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching Kiniksa Pharmaceuticals, Ltd.?

The following analysts have recently covered Kiniksa Pharmaceuticals:

BofA Global Research
Evercore ISI
Goldman Sachs
J.P. Morgan
Marktfeld
Wedbush Securities Inc.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Kiniksa Pharmaceuticals, Ltd.?

The following sell-side analysts have recently covered Kiniksa Pharmaceuticals:

Meacham, Geoffrey Christopher
Bayko, Liisa Ann
Choi, Paul
Rama, Anupam
Paraskevopoulos, Michail
Nierengarten, David Matthew
(This information refers to the last 90 days.)